SN
Sanskar Nawal Kumar Tated
About Sanskar Nawal Kumar Tated
Data last updated:
Sanskar Nawal Kumar Tated is a Director at Africure Pharmaceuticals (India) Private Limited (since 2017). The company operates in Pharma. Africure Pharmaceuticals (India) Private Limited reported revenue of ₹66.93 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Feb 2017 | 2017 | ₹66.93 Cr (FY 2025) | Active |
Board colleagues of Sanskar Nawal Kumar Tated
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ravi Shankar Chandrasekhar | 06944927 | Africure Pharmaceuticals (India) Private Limited | Director |
| Susan Teresa Noronha | 02704190 | Africure Pharmaceuticals (India) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanskar Nawal Kumar Tated
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanskar Nawal Kumar Tated
Sanskar Nawal Kumar Tated currently holds 1 directorship: Africure Pharmaceuticals (India) Private Limited (Director, since 21 Feb 2017, revenue ₹66.93 Cr (FY 2025)).
Sanskar Nawal Kumar Tated was first appointed on 21 Feb 2017 as Director at Africure Pharmaceuticals (India) Private Limited.
The current boards of Sanskar Nawal Kumar Tated's companies include Ravi Shankar Chandrasekhar (Africure Pharmaceuticals (India) Private Limited), Susan Teresa Noronha (Africure Pharmaceuticals (India) Private Limited).